SCAI Expert consensus statement: Evaluation, management, and special considerations of cardio-oncology patients in the cardiac catheterization laboratory (endorsed by the cardiological society of india, and sociedad Latino Americana de Cardiologıa interve-Reference-Cited by-同舟云学术

SCAI Expert consensus statement: Evaluation, management, and special considerations of cardio-oncology patients in the cardiac catheterization laboratory (endorsed by the cardiological society of india, and sociedad Latino Americana de Cardiologıa interve

Published:2016-01-12 Issue:5 Volume:87 Page:E202-E223
ISSN:1522-1946
Container-title:Catheterization and Cardiovascular Interventions
language:en
Short-container-title:Cathet. Cardiovasc. Intervent.

Author:

Iliescu Cezar A.¹,Grines Cindy L.²,Herrmann Joerg³,Yang Eric H.⁴,Cilingiroglu Mehmet⁵⁶,Charitakis Konstantinos⁷,Hakeem Abdul⁸,Toutouzas Konstantinos P.⁹,Leesar Massoud A.¹⁰,Marmagkiolis Konstantinos¹¹¹²

Affiliation:

1. MD Anderson Cancer Center; University of Texas; Houston Texas

2. Detroit Medical Center; Cardiovascular Institute; Detroit Michigan

3. Division of Cardiovascular Diseases; Mayo Clinic; Rochester Minnesota

4. Division of Cardiology; University of California at Los Angeles; Los Angeles California

5. School of Medicine; Arkansas Heart Hospital; Little Rock Arkansas

6. Department of Cardiology; Koc University; Istanbul Turkey

7. Department of Cardiology; University of Texas Health Science Center; Houston Texas

8. Department of Cardiology; University of Arkansas for Medical Sciences; Little Rock Arkansas

9. Athens Medical School; Hippokration General Hospital; Athens Greece

10. Division of Cardiovascular Disease; University of Alabama at Birmingham; Birmingham Alabama

11. Department of Cardiology; Citizens Memorial Hospital; Bolivar Missouri

12. Department of Medicine; University of Missouri; Columbia Missouri

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ccd.26379/fullpdf

Reference236 articles.

1. 2011 http://www.cdc.gov/cancer/dcpc/data/

2. 5 flourouracil-induced apical ballooning syndrome: A case report;Gianni;Blood Coagul Fibrinolysis,2009

3. 5-Fluorouracil induces arterial vasocontractions;Sudhoff;Ann Oncol,2004

4. Cardiotoxicity in cancer patients treated with 5-fluorouracil or capecitabine: A systematic review of incidence, manifestations and predisposing factors;Polk;Cancer Treat Rev,2013

5. Cardiotoxicity of 5-fluorouracil and capecitabine in a pancreatic cancer patient with a novel mutation in the dihydropyrimidine dehydrogenase gene;Shahrokni;JOP,2009

Cited by 140 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of chemotherapy in tumor on coronary arteries: Mechanisms and management;Life Sciences;2024-02

2. Cancer-related arterial thromboembolic events;Archives of Cardiovascular Diseases;2024-01

3. Coronary Artery and Peripheral Vascular Disease in a Patient with Poorly Differentiated Thyroid Cancer Treated with the Tyrosine Kinase Inhibitor Lenvatinib;Case Reports in Endocrinology;2023-10-31

4. Global Registry of Acute Coronary Events Score Underestimates Post-Acute Coronary Syndrome Mortality among Cancer Patients;Cancers;2023-10-30

5. Simplified rules-based tool to facilitate the application of up-to-date management recommendations in cardio-oncology;Cardio-Oncology;2023-10-27